GB

Gwenoline Borhis

Senior Scientist II at Mestag Therapeutics

Gwenoline Borhis has worked in a variety of roles in the scientific field since 2004. Gwenoline began their career as a PhD student at INSERM in 2004, followed by a PhD student role at CEA in 2007. In 2009, they took on a Post-Doctoral Research Associate role at Imperial College before becoming a Post-Doctoral Scientist at INSERM in 2011. From 2015 to 2022, they held two roles at Kymab Ltd, first as a Senior Research Scientist 1 and then as a Research Scientist 2. Her current role is Senior Scientist II at Mestag Therapeutics.

Gwenoline Borhis received their MSc/DEA in Structure & Function of Integrative Biological Systems from Paris-Sud University (Paris XI) in 2003-2004. Gwenoline then continued their studies at the same university, earning their PhD in Immunology in 2008.

Location

Cambridge, United Kingdom

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Mestag Therapeutics

Mestag was founded in 2020 by leading investigators and SV Health Investors to develop new medicines for people affected by inflammatory disease and cancer.


Employees

11-50

Links